Biotech

All Articles

J &amp J goes down phase 2 dengue candidate in most recent shift coming from vaccines

.Johnson &amp Johnson's deprioritization of its own transmittable disease pipe has actually stated a...

Relay sheds 10% of personnel after earlier layoffs in July

.Preciseness medication biotech Relay Therapeutics is shedding approximately 10% of its staff in ini...

Pentixapharm scores $22M IPO to accommodation radiopharma trials

.Pentixapharm has brought in almost twenty million europeans ($ 22 million) coming from an IPO, alon...

Lundbeck faucets Charles Stream for AI-enabled neuro medication breakthrough

.Lundbeck has tapped Charles Stream Laboratories' artificial intelligence capabilities to help the b...

Big pharma, biotech 'won't essentially be symbiotic' in AI: S&ampP

.Significant Pharma is actually putting in intensely in artificial intelligence to reduce progressio...

I &amp I biotech Triveni increases $115M for preclinical antibodies

.Triveni Bio has actually trapped $115 thousand in series B funds to evolve preclinical antibody sys...

IGM turns from cancer to autoimmune, shocking C-suite

.IGM Biosciences finished last year laying off team as well as simplifying its own cancer cells pipe...

Shattuck centers CD47 course over weak efficacy records, lays off 40% of workers as well as sheds Ono work

.Shattuck Labs has actually hammered one more nail in to the coffin of CD47. After finding a "reason...

BioMarin goes Camping outdoors, striking RNA manage biotech

.BioMarin is actually adding kindling to the R&ampD fire, assaulting a match along with CAMP4 Therap...

Cash- strapped Gritstone starts hunt for tactical options as cancer cells injection data underwhelm

.Gritstone bio has actually produced bankers to look into "possible value-maximizing techniques" aft...